Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial User D-R-AZ, in the Covid_Defense subreddit, 09 Jul 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial User D-R-AZ, in the Novel Coronavirus (COVID-19) subreddit, 09 Jul 2020
Remdesivir for severe Covid-19: A randomised double-blind placebo-control trial [pdf] User bprogramming, in the Better Programming subreddit, 12 May 2020
"Remdesivir use was not associated with a difference in time to clinical improvement" User stefantalpalaru, in the Venite a cazzeggiare un po' subreddit, 12 May 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. In this study of adult patients admitted to hospital for severe COVID-19, **remdesivir was not associated with statistically significant clinical benefits. ** User hoyeto, in the China novel coronavirus (2019-nCoV) | "NCVIP" subreddit, 30 Apr 2020
COVID-19: First randomised trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits. No statistically significant difference in time to clinical improvement was noted between the groups (21 days for remdesivir vs 23 days placebo), more research needed. User WoodenFootball, in the Reddit Science subreddit, 29 Apr 2020
Love how GILEAD quickly got ahead of this lancet study showing their drug doesn’t work in a double blind study compared to their shit study and no one is bothering to pay attention User patrickbateman02, in the #TraderLivesMatter subreddit, 29 Apr 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial User pastelsonly, in the COVID-19 subreddit, 29 Apr 2020